Facultad de Ingeniería, UNER
Oro Verde, Entre Ríos Province, 3100, Argentina
NCT Number: NCT07774429
This study evaluates the test-retest reliability of psychophysical responses to non-injurious sharp stimuli applied via a robotic system. The accurate assessment of acute mechanical pain, such as the pain associated with surgical incisions or non-suicidal self-injury, is challenging due to the subjectivity of pain and the risk of tissue damage with traditional mechanical stimulation methods. To overcome this barrier, researchers have developed a non-injurious sharp blade model that mimics the sensory characteristics of incisional pain without causing tissue damage. However, manual application of this blade introduces operator-dependent variability in force, speed, and duration. This study utilizes a novel robotic stimulator equipped with a non-injurious blade to deliver controlled stimuli. The experimental design involves healthy adult volunteers with two identical testing sessions separated by a minimum interval of 48 hours. During these sessions, participants undergo quantitative sensory testing (QST), including the evaluation of pain and tolerance thresholds using the robotic system on the ventral forearm. Additional measurements include pain threshold to pinprick stimulation, muscle stiffness, pain catastrophizing (Sullivan et al., 1995), and conditioned pain modulation.
These results will establish the precision and reliability of this robotic system that are required for further clinical and experimental pain research.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Oro Verde, Entre Ríos Province, 3100, Argentina
Pain is a global health problem involving physiological, psychological, and contextual dimensions that complicate its objective and reproducible evaluation, even in well-controlled environments. Acute mechanical pain, particularly pain associated with surgical incisions or cutting lesions, is of special clinical relevance. It constitutes a central component of postoperative pain and is frequently observed in non-suicidal self-injury contexts. Specifically, in individuals with Borderline Personality Disorder (BPD), over 80% report the use of cutting as an emotional tension regulation strategy. Given the complexity of evaluating this phenomenon, standardized Quantitative Sensory Testing (QST) is essential to determine the state of the somatosensory system in both patients and experimental models. QST measures the intensity at which a stimulus produces a specific sensory perception. However, traditional mechanical QST modalities (e.g., von Frey filaments, pinprick) have a critical limitation: strong stimuli can provoke actual tissue damage. To address this, a non-injurious sharp blade model was developed, allowing the reproduction of the initial sensory characteristics of incisional pain without causing injury (such as sharp pain, primary, and secondary hyperalgesia). While this model has been successfully tested in healthy volunteers and BPD patients, its manual application depends heavily on the operator, leading to involuntary fluctuations in speed, force, and duration. To solve this, a robotic system (Poux et al., 2025) can apply these controlled mechanical stimuli, increasing precision, controlling the applied force, and allowing exact synchronization with electrophysiological recordings. The recent incorporation of an interchangeable head featuring the non-injurious blade model enables the first-ever exploration of non-injurious sharp mechanical stimulation applied via robotics.
The primary objective of this protocol is to evaluate the reliability of psychophysical responses to non-injurious sharp stimuli applied by the robotic system.
The sample size was determined based on the desired precision for estimating the repeatability of the system. Specifically, the objective was to estimate the within-subject standard deviation. The precision with which we can estimate the standard deviation depends on both the number of subjects N and the number of observations per subject M (Bland, 2010) with a 95% confidence interval and a margin of error of ±25% was proposed, from which it is determined that the participation of N = 31 volunteers and M = 2 observations per volunteer is required. To account for a potential 5% dropout rate, the final recruited sample size is N = 33. The volunteers undergo two identical sessions: a baseline session and a re-evaluation session, separated by an interval of at least 48 hours.
During each sessions, the following procedures will be conducted:
Pain Catastrophizing Scale (PCS): A 13-item self-administered questionnaire (scored on a 0-4 Likert scale) to measure negative and exaggerated coping related to pain experiences, specifically assessing hopelessness, magnification, and rumination.
Muscle Stiffness: Non-invasive evaluation using a portable device (MyotonPRO) applying brief (15 ms) mechanical stimuli to automatically calculate muscle tone, stiffness, and elasticity in the forearm.
Pinprick Pain Threshold: Measured using a customized system
Robot-Controlled Blade Thresholds: The robotic system will apply the non-injurious blade (4 mm x 0.1 mm) to the ventral forearm at a constant speed of 5 mm/s. Following a familiarization stage, participants will use a push-button to indicate their Pain Threshold (when the tactile sensation becomes distinctly painful) and Tolerance Threshold (when the pain becomes unbearable or reaches the 5000 mN safety limit).
Conditioned Pain Modulation (CPM): After establishing baseline blade pain thresholds, participants will submerge their dominant hand up to the wrist in a cold water bath maintained below 4°C for up to two minutes. During immersion, participants will continuously rate their pain on a computerized Visual Analog Scale (VAS) from 0 to 100. Immediately after withdrawing the hand, the robotic blade thresholds will be re-evaluated to measure the descending pain inhibition system.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Application of controlled mechanical stimuli using a robotic system equipped with a non-injurious blade head (4 mm x 0.1 mm). The system applies progressive force at a constant speed of 5 mm/s on the ventral forearm to determine pain and tolerance thresholds.
Time frame: Day 1 and Day 3
The amount of force (in grams) at which a tactile sensation is perceived as painful, assessed using the robot-controlled non-injurious blade.
Time frame: Day 1 and Day 3
The difference in non-injurious blade pain thresholds (in grams) measured before and immediately after the application of a cold-water conditioning stimulus. A positive difference indicates an effective descending pain inhibition response.
Time frame: Day 1 and Day 3
The amount of force (in grams) at which a tactile sensation is perceived as painful, assessed using a customized device stimulator, as a secondary comparison measure to the robot-controlled blade.
Time frame: Baseline
Assessment of the statistical relationship between resting muscle stiffness (measured non-invasively in N/m using the MyotonPRO device) and the mechanical pain and tolerance thresholds (in grams) obtained with the non-injurious robotic blade.
Time frame: Baseline
Assessment of the statistical relationship between the psychological tendency to catastrophize pain (measured by the total score of the 13-item Pain Catastrophizing Scale, PCS) and the pain and tolerance thresholds (in grams) obtained with the non-injurious robotic blade.
National Council of Scientific and Technical Research, Argentina
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07330167
Neurologic Manifestations, Pain
Vaxjo, Kronoberg County, Sweden
View Trial DetailsNCT06840743
Neurologic Manifestations, Pain
Vaxjo, Sweden
View Trial DetailsNCT05714020
Electroencephalography, Motor Cortex
Gistrup, North Denmark, Denmark
View Trial DetailsNCT06851208
Neurologic Manifestations, Pain
View Trial Details